Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,683 | -52,540 | -33,617 | -27,584 | -14,891 |
| Depreciation Amortization | 664 | 2,663 | 1,556 | 666 | 325 |
| Accounts receivable | -3,395 | -1,274 | -4,298 | 405 | -898 |
| Accounts payable and accrued liabilities | -1,305 | -2,714 | -1,888 | -3,402 | -3,085 |
| Other Working Capital | 1,372 | -10,517 | -14,404 | -5,298 | -6,337 |
| Other Operating Activity | 7,608 | 17,401 | 16,501 | 9,944 | 7,521 |
| Operating Cash Flow | $-14,739 | $-46,981 | $-36,150 | $-25,269 | $-17,365 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,045 | -5,086 | -4,262 | -2,056 | -187 |
| Purchase Of Investment | 70 | -1,062 | -394 | -530 | -530 |
| Investing Cash Flow | $-1,975 | $-6,148 | $-4,656 | $-2,586 | $-717 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 70,000 | 70,000 | N/A | N/A |
| Debt Repayment | 0 | N/A | N/A | -19 | N/A |
| Common Stock Issued | 2,185 | 53,044 | 5,849 | 3,437 | 2,984 |
| Other Financing Activity | 0 | -3,677 | -3,668 | -674 | -29 |
| Financing Cash Flow | $2,185 | $119,367 | $72,181 | $2,744 | $2,955 |
| Exchange Rate Effect | -547 | 323 | 251 | 159 | 150 |
| Beginning Cash Position | 149,613 | 83,052 | 83,052 | 83,052 | 83,052 |
| End Cash Position | 134,537 | 149,613 | 114,678 | 58,100 | 68,075 |
| Net Cash Flow | $-15,076 | $66,561 | $31,626 | $-24,952 | $-14,977 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,739 | -46,981 | -36,150 | -25,269 | -17,365 |
| Capital Expenditure | -2,045 | -5,086 | -4,262 | -2,056 | -187 |
| Free Cash Flow | -16,784 | -52,067 | -40,412 | -27,325 | -17,552 |